Arvinas (ARVN) Times Interest Earned (2017 - 2021)
Arvinas (ARVN) posted quarterly Times Interest Earned of -$16.36 for Q1 2026, down 370.36% year-over-year from $6.05 in Q1 2025, and up 91.23% quarter-over-quarter from -$186.5 in Q4 2025.
Powered by 
Analysis
Arvinas (ARVN) Times Interest Earned (2017 - 2021) Analysis & Trends
Arvinas' Times Interest Earned history runs 10 years deep, the most recent figure standing at -$16.36 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 370.36% year-over-year to -$16.36; the TTM figure through Mar 2026 stood at -$65.05 (down 702.93% YoY), while the FY2025 annual figure was -$0.25, up 53.62% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$16.36, up from -$186.5 in the prior quarter.
- The five-year high for Times Interest Earned was $6.05 in Q1 2025, with the low at -$330.6 in Q4 2023.
- The 5-year median for Times Interest Earned is -$28.6 (2025), against an average of -$58.95.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned tumbled 50459.2% in 2022, then surged 114.53% in 2025.
- Arvinas' Times Interest Earned stood at -$34.36 in 2022, then plunged by 862.06% to -$330.6 in 2023, then soared by 90.22% to -$32.33 in 2024, then tumbled by 476.8% to -$186.5 in 2025, then jumped by 91.23% to -$16.36 in 2026.
- Business Quant data shows ARVN's Times Interest Earned at -$16.36 in Q1 2026, -$186.5 in Q4 2025, and -$17.52 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Arvinas | 609.77 Mn | 41.87 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -703.70 |
| Sep 30, 2021 | -5,821.54 |
| Jun 30, 2021 | -6,387.69 |
| Mar 31, 2021 | -2,566.15 |
| Dec 31, 2020 | -764.02 |
| Sep 30, 2020 | -1,953.73 |
| Jun 30, 2020 | -1,629.78 |
| Mar 31, 2020 | -1,440.74 |
| Dec 31, 2019 | -1,402.46 |
| Sep 30, 2019 | 240.35 |
| Jun 30, 2019 | -808.89 |
| Mar 31, 2019 | -669.03 |
| Dec 31, 2018 | -687.76 |
| Sep 30, 2018 | -1,146.35 |
| Jun 30, 2018 | -862.89 |
| Mar 31, 2018 | -401.36 |
| Dec 31, 2017 | -463.45 |
| Sep 30, 2017 | -524.70 |
| Jun 30, 2017 | -518.36 |
| Mar 31, 2017 | -460.67 |